Ryan Specialty Holdings, Inc. (RYAN) Balance Sheet

The Q3 2026 equity drop from $636.2M to $446.7M is large relative to reported net income of $36.7M, which suggests buybacks of $150.1M and other equity movements may be driving the change rather than earnings alone. Total assets grew from $8.3B in Q2 2024 to roughly $11.0B in Q3 2026, indicating the balance sheet is expanding faster than the equity base. Investors should monitor whether this asset growth continues to be funded predominantly by liabilities.

Because RYAN is a brokerage and MGU platform rather than a risk-bearing carrier, its liabilities are largely fiduciary and payable obligations rather than policyholder reserves, which makes the ratio interpretable differently than for a traditional insurer. Even so, a thin equity base reduces flexibility to absorb impairments in acquired intangibles or a downturn in contingent commissions. The data does not disclose statutory capital, so capitalization adequacy cannot be assessed on a regulatory basis.

Operating cash flow swung from negative quarters such as -$167.4M in Q1 2026 to $181.3M in Q3 2026, which indicates that liquidity depends heavily on fiduciary timing rather than a stable cash base visible on the balance sheet. Investors should verify the consolidated cash balance directly in the filings before drawing liquidity conclusions. Where data is unavailable, no inference about funding capacity is drawn here.

The ROE trajectory, falling to 3.8% in Q3 2026 from 9.7% in Q2 2026, suggests that the equity base expansion is diluting returns, consistent with the prior income statement finding of decelerating growth. Forward earnings visibility appears limited given the absence of guidance and management's description of a tougher comparison period. Investors should monitor whether organic growth holds near the trailing pace.